Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $1,430,000 of ANHEUSER-BUSCH COMPANIES lobbying was just disclosed

None

$1,430,000 of ANHEUSER-BUSCH COMPANIES lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General agriculture issues General policy regarding regulation of the alcohol-beverage industry; Differentiation of beer from cannabis and hemp in tax and regulation; Public Law Number: 119-37; Differentiation of beer from liquor in tax and regulation; TTB regulation of alcohol-beverage industry Public Law No: 119-21 H.R. 1707, Grown in America Act Issues related to tariffs Issues related to seeking transparency around dietary guidelines review and revision process"

You can find more data on corporate lobbying on Quiver Quantitative.

BUD Hedge Fund Activity

We have seen 259 institutional investors add shares of BUD stock to their portfolio, and 219 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • MANUFACTURERS LIFE INSURANCE COMPANY, THE removed 3,760,808 shares (-93.9%) from their portfolio in Q4 2025, for an estimated $240,842,144
  • DODGE & COX removed 3,432,790 shares (-9.4%) from their portfolio in Q4 2025, for an estimated $219,835,871
  • FMR LLC removed 2,940,975 shares (-55.6%) from their portfolio in Q4 2025, for an estimated $188,340,039
  • GQG PARTNERS LLC added 2,338,805 shares (+inf%) to their portfolio in Q4 2025, for an estimated $149,777,072
  • BANK OF MONTREAL /CAN/ removed 1,140,383 shares (-95.9%) from their portfolio in Q4 2025, for an estimated $73,030,127
  • HOLOCENE ADVISORS, LP added 1,039,934 shares (+inf%) to their portfolio in Q4 2025, for an estimated $66,597,373
  • MORGAN STANLEY added 966,378 shares (+29.8%) to their portfolio in Q4 2025, for an estimated $61,886,847

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BUD Analyst Ratings

Wall Street analysts have issued reports on $BUD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Wells Fargo issued a "Overweight" rating on 11/19/2025

To track analyst ratings and price targets for BUD, check out Quiver Quantitative's $BUD forecast page.

BUD Price Targets

Multiple analysts have issued price targets for $BUD recently. We have seen 3 analysts offer price targets for $BUD in the last 6 months, with a median target of $88.0.

Here are some recent targets:

  • Robert Ottenstein from Evercore ISI Group set a target price of $100.0 on 02/13/2026
  • Chris Carey from Wells Fargo set a target price of $88.0 on 02/13/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles